Sleep and lung cancer treatment outcome study
Part of Brain & nervous system, Cancer, Lungs & breathing, Mental health clinical trials.
This study looks at how sleep disturbances affect how well lung cancer treatments work. It may help doctors understand if improving sleep can lead to better treatment results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed diagnosis of non-small cell or small cell lung cancer.
- Your cancer must be at a certain stage (locally advanced, metastatic, or recurrent for some groups, or early stage for others).
- You must not have had any previous cancer treatment for this lung cancer (treatment-naive).
- You must be receiving a specific type of immunotherapy (PD-1/PD-L1 inhibitors) or targeted therapy, depending on the group you join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether psychological stress changes how well lung cancer treatments work and what the outlook is. You may qualify if you’re about to start (or recently started) certain immunotherapy-based treatments, and you can complete stress and well-being questionnaires.
This trial is looking at how well a lung cancer treatment improves survival. It enrolls adults with confirmed lung cancer who can safely take the study medicines and have cancer that can be measured on scans.
This study helps hospitals use the latest lung cancer guidelines better. If you have NSCLC or ES-SCLC and haven't had recent treatment, this trial may help improve the quality of care you receive.
This study looks at how sleep problems affect your body's immune response to lung cancer. It aims to find links between sleep and the tumor environment, which could help improve treatment.
This study looks at how sleep problems affect immunotherapy for people with lung cancer. If you have non-small-cell lung cancer and are about to start immunotherapy, you may be able to join.
This study looks at how sleep disorders may relate to the development of lung tumors, especially in people having surgery. It may help doctors understand risk factors tied to sleep and improve how patients are evaluated and cared for.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.